Health Winners & Losers: Thermage (at TheStreet.com)

Thursday proved to be another droopy day for health stocks, as news kept on the light side and investor sentiment continued to mimic the broader markets. The Nasdaq and Amex biotechnology indices were down 0.8% and 0.7%, respectively. The Amex Pharmaceutical Index was off by just 0.07%. Pharma components Bristol-Myers SquibbBMY and AstraZenecaAZN managed to buck the trend, gaining 1.7% and 1.8%, respectively. ThermageTHRM soared Thursday after the company said it received a revised unsolicited bid from a third party, putting its pending acquisition of Reliant Technologies in doubt. Thermage, which makes devices for wrinkle treatments, would receive $5.50 a share, in cash or a combination of cash and stock, in the third-party bid. The company, which in July that it would buy laser skin resurfacing company Reliant Technologies... [read full story]